NCT00819520View on ClinicalTrials.gov

Ivermectin in the Treatment of Head Lice

PHASE3CompletedINTERVENTIONAL
Enrollment

812

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

September 30, 2004

Study Completion Date

October 31, 2004

Conditions
Lice Infestations
Interventions
DRUG

ivermectin

Two single doses of oral ivermectin 400 mcg/kg (Days 1 and 8) plus 2 single applications of placebo lotion

DRUG

malathion

Two single applications of malathion 0.5% lotion (Days 1 and 8) plus 2 single doses of placebo tablets

Trial Locations (4)

52621

Chaim Sheba Medical Centre, Tel Litwinsky

93009

Hopital Avicenne, Bobigny

Unknown

Shandon Clinic, Cork

RG2 7AG

Synexus Clinical Research Centre, Reading

All Listed Sponsors
lead

Johnson & Johnson Consumer and Personal Products Worldwide

INDUSTRY

NCT00819520 - Ivermectin in the Treatment of Head Lice | Biotech Hunter | Biotech Hunter